A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4
Rondo Therapeutics
Rondo Therapeutics
Huabo Biopharm Co., Ltd.
Tolmar Inc.
Stella Pharma Corporation
Gene Solutions
A2 Biotherapeutics Inc.
VitaMed Research LLC
Concr